title: Factor VIII inhibitor eradication with bortezomib in acquired haemophilia A.
authors.affiliation: Department of Clinical Haematology, Alfred Hospital, Melbourne, Australia.
authors.forename: James D
authors.initials: JD
authors.lastname: McFadyen
authors.affiliation: Department of Clinical Haematology, Alfred Hospital, Melbourne, Australia.
authors.forename: Huyen
authors.initials: H
authors.lastname: Tran
authors.affiliation: Department of Clinical Haematology, Alfred Hospital, Melbourne, Australia.
authors.forename: Zane S
authors.initials: ZS
authors.lastname: Kaplan
mesh_terms: D019774:Blood Coagulation Factor Inhibitors / Q000037:antagonists & inhibitors*; D000069286:Bortezomib / Q000627:therapeutic use*; D005169:Factor VIII / Q000037:antagonists & inhibitors* / Q000276:immunology*; D006406:Hematoma / Q000000981:diagnostic imaging / Q000209:etiology; D006467:Hemophilia A / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology*; D006801:Humans; D007518:Isoantibodies / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D061988:Proteasome Inhibitors / Q000627:therapeutic use; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
chemical_list: D019774:Blood Coagulation Factor Inhibitors; D007518:Isoantibodies; D061988:Proteasome Inhibitors; D000069286:Bortezomib; D005169:Factor VIII
keywords: bleeding disorders; blood coagulation; haemophilia